Retatrutide is a new pharmaceutical in the fight against obesity. This novel drug, belonging to a dual GLP-1 and GIP receptor agonist, shows promising results in research studies. By boosting these receptors, https://georgiawtup067412.blogdemls.com/36154421/tirzepatide-a-promising-new-treatment-for-obesity